Athens Medical C.S.A. (IATR.AT)
EUR 1.88
(-2.34%)
EUR 1.88
(-2.34%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 38.08 Million EUR | 1.52% |
| 2022 | 32.25 Million EUR | -48.6% |
| 2021 | 34.9 Million EUR | 28.15% |
| 2020 | 22.06 Million EUR | -6.93% |
| 2019 | 28.41 Million EUR | 11.72% |
| 2018 | 23.99 Million EUR | 111.75% |
| 2017 | 23.22 Million EUR | 1.09% |
| 2016 | 23.31 Million EUR | 263.59% |
| 2015 | 1.18 Million EUR | -70.96% |
| 2014 | 898 Thousand EUR | 127.0% |
| 2013 | 10.27 Million EUR | -86.31% |
| 2012 | 16.51 Million EUR | 666.67% |
| 2011 | 9.78 Million EUR | 32.8% |
| 2010 | 7.37 Million EUR | -53.17% |
| 2009 | 15.73 Million EUR | -54.47% |
| 2008 | 34.57 Million EUR | -20.88% |
| 2007 | 43.69 Million EUR | 6.34% |
| 2006 | 43.99 Million EUR | 10.21% |
| 2005 | 38.62 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 10.96 Million EUR | 0.0% |
| 2024 Q1 | 10.96 Million EUR | -16.33% |
| 2023 Q4 | 13.1 Million EUR | 0.0% |
| 2023 FY | - EUR | 1.52% |
| 2023 Q1 | 10.78 Million EUR | -23.18% |
| 2023 Q2 | 23.53 Million EUR | 118.17% |
| 2022 Q3 | 6.13 Million EUR | -62.34% |
| 2022 Q4 | 14.04 Million EUR | 129.02% |
| 2022 Q1 | 7.68 Million EUR | -50.14% |
| 2022 FY | - EUR | -48.6% |
| 2022 Q2 | 16.28 Million EUR | 111.95% |
| 2021 Q1 | 8.35 Million EUR | -32.16% |
| 2021 Q3 | 7.39 Million EUR | -58.72% |
| 2021 Q4 | 15.41 Million EUR | 108.5% |
| 2021 FY | - EUR | 28.15% |
| 2021 Q2 | 17.9 Million EUR | 114.44% |
| 2020 Q2 | 7.52 Million EUR | 115.76% |
| 2020 FY | - EUR | -6.93% |
| 2020 Q3 | 5.7 Million EUR | -24.2% |
| 2020 Q1 | 3.48 Million EUR | -63.24% |
| 2020 Q4 | 12.3 Million EUR | 115.66% |
| 2019 Q3 | 3.92 Million EUR | -75.12% |
| 2019 Q2 | 15.79 Million EUR | 87.84% |
| 2019 FY | - EUR | 11.72% |
| 2019 Q1 | 8.4 Million EUR | 93.42% |
| 2019 Q4 | 9.49 Million EUR | 141.68% |
| 2018 Q2 | 7.5 Million EUR | 0.0% |
| 2018 FY | - EUR | 111.75% |
| 2018 Q4 | 4.34 Million EUR | 0.0% |
| 2018 Q3 | 4.34 Million EUR | -42.05% |
| 2018 Q1 | 7.5 Million EUR | 62.74% |
| 2017 Q3 | 4.6 Million EUR | -34.23% |
| 2017 Q2 | 7 Million EUR | 0.0% |
| 2017 FY | - EUR | 1.09% |
| 2017 Q4 | 4.6 Million EUR | 0.0% |
| 2017 Q1 | 7 Million EUR | 5.94% |
| 2016 FY | - EUR | 263.59% |
| 2016 Q2 | 4.99 Million EUR | 0.0% |
| 2016 Q1 | 4.99 Million EUR | 120.17% |
| 2016 Q4 | 6.61 Million EUR | 0.0% |
| 2016 Q3 | 6.61 Million EUR | 32.53% |
| 2015 Q2 | 7.51 Million EUR | -39.61% |
| 2015 Q1 | 12.45 Million EUR | 655.6% |
| 2015 FY | - EUR | -70.96% |
| 2015 Q4 | -24.74 Million EUR | -531.68% |
| 2015 Q3 | 5.73 Million EUR | -23.75% |
| 2014 Q3 | 6.09 Million EUR | -33.95% |
| 2014 Q2 | 9.22 Million EUR | -9.84% |
| 2014 Q1 | 10.23 Million EUR | 141.55% |
| 2014 Q4 | -2.24 Million EUR | -136.77% |
| 2014 FY | - EUR | 127.0% |
| 2013 Q4 | -24.63 Million EUR | -390.3% |
| 2013 Q2 | 13.74 Million EUR | 8.52% |
| 2013 FY | - EUR | -86.31% |
| 2013 Q1 | 12.67 Million EUR | -44.25% |
| 2013 Q3 | 8.48 Million EUR | -38.29% |
| 2012 Q2 | 4.97 Million EUR | -75.26% |
| 2012 Q3 | 10.74 Million EUR | 116.17% |
| 2012 Q4 | 22.72 Million EUR | 111.43% |
| 2012 FY | - EUR | 666.67% |
| 2012 Q1 | 20.09 Million EUR | 63.7% |
| 2011 Q3 | -6.49 Million EUR | -365.25% |
| 2011 Q1 | 3.7 Million EUR | 289.62% |
| 2011 Q4 | 12.27 Million EUR | 288.98% |
| 2011 Q2 | 2.44 Million EUR | -33.94% |
| 2011 FY | - EUR | 32.8% |
| 2010 FY | - EUR | -53.17% |
| 2010 Q1 | 9.02 Million EUR | 212.79% |
| 2010 Q2 | 5.18 Million EUR | -42.57% |
| 2010 Q3 | -4.32 Million EUR | -183.51% |
| 2010 Q4 | -1.95 Million EUR | 54.81% |
| 2009 Q4 | -7.99 Million EUR | -374.81% |
| 2009 Q3 | 2.91 Million EUR | -30.03% |
| 2009 Q2 | 4.15 Million EUR | 0.0% |
| 2009 FY | - EUR | -54.47% |
| 2008 Q3 | 1.67 Million EUR | 0.0% |
| 2008 FY | - EUR | -20.88% |
| 2008 Q4 | 7.16 Million EUR | 327.9% |
| 2007 FY | - EUR | 6.34% |
| 2006 FY | - EUR | 10.21% |
| 2005 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|